Abu Dhabi, United Arab Emirates
+919405476170
+919405476170
ANTI CANCER MEDICINE by OXALIEVA

Buy Oxalieva Injection Online: View Uses, Side Effects

In stock•cod not available
Phone Number

+919405476170

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Abu Dhabi , Abu Dhabi Region , Abu Dhabi

Abu Dhabi, United Arab Emirates, United Arab Emirates, 1

Description

OXALIEVA 100 MG Injection (Oxaliplatin): Advanced Platinum-Based Cytotoxic Therapy OXALIEVA 100 MG Injection is a high-potency antineoplastic medication containing the active pharmaceutical ingredient Oxaliplatin. Classified as a third-generation organoplatinum complex, it is a critical pillar in the systemic treatment of various solid tumors. Manufactured under stringent WHO-GMP guidelines, OXALIEVA 100 MG is engineered to deliver targeted cytotoxic effects, making it a primary choice for oncologists managing advanced-stage malignancies across the globe. Therapeutic Indications and Clinical Usage Metastatic Colorectal Cancer (mCRC): Indicated as a first-line or subsequent therapy, typically in combination with 5-fluorouracil (5-FU) and leucovorin (the FOLFOX regimen). Adjuvant Treatment of Colon Cancer: Used for Stage III colon cancer in patients who have undergone complete surgical resection of the primary tumor to prevent recurrence. Advanced Gastric and Esophageal Cancers: Frequently employed in perioperative and palliative settings. Pancreatic Adenocarcinoma: A core component of the multi-drug FOLFIRINOX regimen for metastatic or locally advanced disease. Hepatobiliary Malignancies: Used in specialized treatments for gallbladder and biliary tract cancers. Mechanism of Action: How OXALIEVA 100 MG Works Non-Enzymatic Activation: Upon administration, Oxaliplatin undergoes biotransformation into reactive derivatives. DNA Binding: These reactive species bind to the DNA bases (specifically guanine and adenine), creating intra-strand cross-links. Inhibition of DNA Synthesis: These cross-links physically block the DNA from unwinding and replicating. Evasion of Repair Mechanisms: Unlike older platinum agents (cisplatin), the bulky 1,2-diaminocyclohexane (DACH) ring in Oxaliplatin prevents the cell’s mismatch repair proteins from fixing the damage. Programmed Cell Death: The irreversible structural damage triggers cellular apoptosis, effectively halting tumor growth and the spread of metastasis. Professional Administration and Safety Protocols Route: Administered strictly via Intravenous (IV) Infusion. Dilution Warning: Must be diluted only with 5% Dextrose Injection (D5W). It is chemically incompatible with chloride-containing solutions (like normal saline), which can cause drug degradation. Infusion Timing: Usually administered over a period of 2 to 6 hours. Clinical Oversight: Must be administered by qualified oncology professionals in a setting equipped for continuous patient monitoring and management of infusion-related reactions. Safety Profile and Clinical Monitoring Neurological Monitoring: Vigilance for acute and cumulative peripheral sensory neuropathy, often triggered or exacerbated by exposure to cold. Hematological Checks: Regular Complete Blood Counts (CBC) are mandatory to monitor for bone marrow suppression (neutropenia, anemia, and thrombocytopenia). Hepatic Vigilance: Periodic liver function tests (LFTs) to monitor for potential sinusoidal obstruction syndrome. Hypersensitivity: Immediate monitoring for allergic reactions during and after the infusion is standard clinical practice. Storage and Global Handling Instructions Storage: Store in the original carton at controlled room temperature (20°C to 25°C). Do not freeze. Light Sensitivity: Protect the vial from prolonged light exposure. Handling: As a hazardous cytotoxic drug, OXALIEVA 100 MG must be prepared and handled using appropriate Personal Protective Equipment (PPE) and disposed of according to international biohazard protocols. Why Choose Ernest Oncology? 100% Genuine Medication: We source directly from GMP-certified channels, ensuring every vial is authentic with an optimal shelf life. Global Distribution Network: Secure and rapid shipping to the USA, UK, UAE, Australia, Singapore, South Africa, Europe, Middle East, Africa, and Asia. Logistics Precision: Our team manages pharmaceutical exports with expertise, utilizing secure packaging and efficient transit routes to maintain product stability during long-distance transit. Regulatory Support: We handle all necessary export paperwork, including Certificates of Analysis (CoA) and permits, for seamless customs clearance. Bulk Supplier Advantage: As a dedicated distributor, we offer competitive wholesale rates to support oncology hospitals, clinics, and government health departments worldwide. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct WhatsApp Connection

Keywords

Other Products

view all

68179d65be22ee500d53ff54 Card 2

product image
ANTI CANCER MEDICINE

About Imatinib Mesylate Tablets Imatinib Mesylate Tablets are prescription oncology medicines belonging to the tyrosine kinase inhibitor (TKI) class. They are widely used in specialized oncology and hematology treatment programs under the supervision of qualified medical professionals. The tablets are manufactured following stringent pharmaceutical quality standards and supplied to regulated healthcare markets through licensed distribution networks. Product Profile Specification: Information Generic Name: Imatinib Mesylate Dosage Form: Oral Tablets Available Strengths: 100 mg & 400 mg Therapeutic Category: Oncology Medicine Drug Class: :Tyrosine Kinase Inhibitor (TKI) Prescription Status: Prescription Only Country of Origin: India Medical Applications: Hematology treatment programs Oncology management protocols Long-term physician-supervised therapy Hospital cancer care services Specialized oncology clinics Clinical treatment pathways Safety & Clinical Guidance: Use the medicine only under medical supervision. Attend scheduled follow-up appointments. Inform healthcare providers about existing medical conditions and concurrent medications. Follow laboratory monitoring recommendations when advised. Report unusual symptoms promptly to the treating physician. Why Choose Our Pharmaceutical Export Services: Consistent international product availability Bulk supply for institutional buyers Experienced pharmaceutical export team Timely worldwide dispatch Complete export documentation support Quality-focused sourcing network Competitive commercial pricing Regulatory & Export Documentation Certificate of Analysis (COA) Certificate of Origin (COO) Commercial Invoice Packing List Batch Certificate Product Specification Sheet Manufacturing Compliance Docum Imatinib Mesylate Tablets 100 mg Imatinib Mesylate Tablets 400 mg Dasatinib Tablets Nilotinib Capsules Bosutinib Tablets Ponatinib Tablets Erlotinib Tablets Gefitinib Tablets Frequently Asked Questions 1. Which strengths of Imatinib Mesylate Tablets are available for export? The commonly supplied strengths are 100 mg and 400 mg, subject to manufacturer availability and destination market requirements. 2. Who can place bulk orders for Imatinib Mesylate Tablets? Licensed pharmaceutical importers, hospitals, oncology distributors, government procurement agencies, and authorized healthcare wholesalers can procure bulk quantities. 3. Are export documents provided with international shipments? Yes. Eligible orders can be accompanied by COA, COO, CPP (where applicable), commercial invoices, packing lists, batch documentation, and other required regulatory documents. 4. Which countries frequently source Imatinib Mesylate Tablets? Demand is strong in the United States (Washington, D.C.), United Kingdom (London), Australia (Canberra), Canada (Ottawa), Singapore, France (Paris), Germany (Berlin), UAE (Abu Dhabi), Saudi Arabia (Riyadh), South Africa (Pretoria), and Nigeria (Abuja). 5. Why do global healthcare buyers choose Indian exporters for Imatinib Mesylate Tablets? Indian pharmaceutical exporters are recognized for supplying quality-assured oncology medicines, dependable bulk availability, competitive commercial pricing, regulatory documentation support, and efficient worldwide distribution tailored to institutional healthcare procurement. #ImatinibMesylate #Imatinib100mg #Imatinib400mg #TyrosineKinaseInhibitor #TargetedTherapy #OncologyMedicine #CancerCare #PharmaceuticalExporter #WholesaleMedicines #HospitalPharmacy #MedicineSupplier #IndianPharma #BulkMedicine #HealthcareDistributor #GlobalHealthcare #MedicalImports #OncologyExport #HealthcareProcurement #CancerMedicineSupplier #ErnestPharmaceutical Online Imatinib Mesylate Tablets Imatinib Mesylate Tablets Supplier India Wholesale Imatinib Tablets Buy Imatinib 100 mg Tablets Imatinib 400 mg Tablet Exporter Tyrosine Kinase Inhibitor Supplier Oncology Tablet Export Company Bulk Cancer Medicine Supplier Pharmaceutical Exporter India 🏥 Your Trusted Global Partner for Oncology Pharmaceuticals [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Bulk Supply 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1

68179d65be22ee500d53ff54 Card 2

product image
ANTI CANCER MEDICINE

Trusted Irinotecan Hydrochloride Injection Supplier from India for Global Pharmaceutical Distribution Irinotecan Hydrochloride Injection USP 20 mg/mL is a sterile prescription oncology medicine classified as a topoisomerase I inhibitor. It is administered by oncology specialists as part of carefully planned chemotherapy protocols in hospital and cancer treatment facilities. Every dose is prepared and infused under controlled clinical conditions to ensure safe administration and patient monitoring. Produced under internationally recognized manufacturing standards, this injectable medicine is supplied to regulated pharmaceutical markets through reliable global export channels. Medical Applications: Colorectal oncology care Gastrointestinal cancer management Advanced oncology treatment Combination chemotherapy protocols Hospital-based cancer therapy Specialist oncology services Safety, Handling & Regulatory Compliance: Irinotecan Injection should be prepared and administered by trained oncology personnel following institutional handling procedures. International shipments can be supported with GMP documentation, quality certificates, batch records, and regulatory documents required by destination markets. Administration Information: This injection is administered by qualified healthcare professionals through intravenous infusion in hospitals or oncology centres. The treatment schedule and dosage are determined according to the patient's clinical condition and approved chemotherapy protocol. Export Documentation Certificate of Analysis (COA) Certificate of Origin (COO) Certificate of Pharmaceutical Product (CPP) (where applicable) GMP Certificate Commercial Invoice Packing List Batch Manufacturing Documents Product Specification Sheet Worldwide Procurement of Injectable Oncology Medicines Continues to Expand The growing demand for advanced cancer treatment has increased procurement of injectable oncology medicines across international healthcare systems. Buyers from hospitals and pharmaceutical distribution companies continue seeking dependable exporters capable of delivering regulatory-compliant products, uninterrupted supply, and efficient worldwide logistics. Oxaliplatin Injection Fluorouracil Injection Leucovorin Calcium Injection Capecitabine Tablets Bevacizumab Injection Cetuximab Injection Gemcitabine Injection Frequently Asked Questions 1. Which strength of Irinotecan Injection is available for export? Irinotecan Hydrochloride Injection USP is commonly supplied as 20 mg/mL, with multiple vial presentations available depending on manufacturer specifications. 2. Who can purchase Irinotecan Injection in bulk? Licensed hospitals, oncology centres, pharmaceutical distributors, government procurement agencies, and authorized importers can place wholesale orders. 3. Is export documentation provided with international shipments? Yes. Eligible shipments may include COA, COO, GMP certificates, CPP (where applicable), commercial invoices, packing lists, and batch documentation. 4. Which countries frequently import Irinotecan Hydrochloride Injection? Major demand comes from the United States (Washington, D.C.), United Kingdom (London), Australia (Canberra), Canada (Ottawa), France (Paris), Germany (Berlin), Singapore, UAE (Abu Dhabi), Saudi Arabia (Riyadh), South Africa (Pretoria), and Nigeria (Abuja). 5. Why do international healthcare buyers source Irinotecan Injection from India? Indian pharmaceutical exporters are recognized for dependable manufacturing quality, strong export capabilities, regulatory documentation support, competitive commercial pricing, and reliable supply solutions for hospitals and healthcare distributors worldwide. Buy Irinotecan Hydrochloride Injection Online Irinotecan Injection USP 20 mg/mL Supplier Wholesale Irinotecan Injection Topoisomerase Inhibitor Supplier Oncology Injection Export Company Bulk Cancer Injection Supplier Injectable Oncology Medicine Export Pharmaceutical Exporter India 🏥 Your Trusted Global Partner for Oncology Pharmaceuticals [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Bulk Supply 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 #IrinotecanInjection #IrinotecanHydrochloride #OncologyInjection #CancerMedicine #Chemotherapy #InjectableMedicines #TopoisomeraseInhibitor #HospitalPharmacy #PharmaceuticalExporter #MedicineSupplier #IndianPharma #BulkMedicine #HealthcareDistributor #GlobalPharma #CancerCare #MedicalImports #OncologyExport #HospitalProcurement #WorldwideHealthcare #ErnestPharmaceutical

68179d65be22ee500d53ff54 Card 2

product image
ANTI CANCER MEDICINE

Ifosfamide Injection (500 mg, 1 g, 2 g) is a widely used cytotoxic medicine from the oxazaphosphorine group, indicated mainly for solid tumors and hematologic malignancies. Key strengths for procurement pages Ifosfamide Injection 500 mg Ifosfamide Injection 1 g Ifosfamide Injection 2 g Dosage forms: single‑dose vials, multi‑strength portfolio (500 mg, 1 g, 2 g) Typical pack configuration: 1 vial per carton, export‑grade secondary packaging Stability and transport: controlled temperature, light‑protected, compliant with standard cold‑chain or ambient logistics according to product specification Provide detailed specification sheets and COAs for regulatory authorities and institutional buyers to support product registration and tender submissions. Indications and Clinical Use Ifosfamide Injection is used in combination chemotherapy regimens for various malignancies, typically in specialist oncology units. As this is a YMYL (Your Money Your Life) pharmaceutical topic, content for public sites should stay informational and avoid therapeutic claims beyond approved labels. Safety, Handling, and Regulatory Compliance Ifosfamide Injection is intended for handling by trained oncology professionals using established safety procedures. International supplies are supported with quality certifications and export documentation based on destination country requirements. Product Specifications Feature Description Generic Name Ifosfamide Dosage Form Sterile Powder for Injection Available Strengths 500 mg, 1 g, 2 g Therapeutic Class Anticancer Medicine Drug Category Alkylating Agent Route Intravenous Administration Prescription Status Hospital Prescription Only Supply Type Bulk Supply & International Export Country of Origin India Clinical Uses: -Soft tissue sarcoma treatment protocols -Bone cancer management -Testicular cancer therapy -Lymphoma treatment plans -Advanced oncology care -Multi-drug chemotherapy programs Wholesale Ifosfamide Injection Supplier Ifosfamide 500 mg for Hospital Procurement Ifosfamide Injection 1 g Bulk Distributor Ifosfamide 2 g Global Pharmaceutical Supply Trusted Oncology Injectable Exporter Cancer Care Injection Supplier Worldwide Sterile Ifosfamide Injection Manufacturer Ifosfamide Oncology Medicine Distributor Bulk Chemotherapy Injection Supplier 🏥 Your Trusted Global Partner for Oncology Pharmaceuticals [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Bulk Supply 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 Frequently Asked Questions 1. Is Ifosfamide Injection supplied for international hospital procurement? Yes. Bulk quantities are available for licensed hospitals, oncology distributors, pharmaceutical importers, and government healthcare organizations. 2. Which strengths of Ifosfamide Injection are available? The commonly supplied strengths include 500 mg, 1 g, and 2 g, depending on manufacturer availability and destination market requirements. 3. How is Ifosfamide Injection administered? It is administered intravenously by qualified healthcare professionals in specialized oncology or hospital settings according to prescribed chemotherapy protocols. 4. What export documents are provided with international orders? Eligible shipments may include COA, COO, CPP (where applicable), commercial invoice, packing list, batch documents, and other regulatory paperwork required by the importing country. 5. Why do international buyers choose Indian exporters for Ifosfamide Injection? Indian pharmaceutical exporters are valued for their ability to provide consistent bulk availability, internationally accepted manufacturing standards, responsive export support, and efficient global distribution networks. This enables hospitals, oncology distributors, and licensed importers to maintain a dependable supply of quality injectable medicines while meeting their procurement and regulatory requirements. Cyclophosphamide Injection Doxorubicin Injection Cisplatin Injection Carboplatin Injection Gemcitabine Injection Etoposide Injection